ACCELERON PHARMA LANDS $30M IN SECOND ROUND

The Cambridge, Mass., company formally announced the news on Wednesday. OrbiMed Advisors in New York led the round, which included previous investors Advanced Technology Ventures in Palo Alto, Calif. and Waltham; Flagship Ventures in Cambridge, Polaris Venture Partners in Waltham, Mass.; Sutter Hill Ventures in Palo Alto and Venrock Associates in Menlo Park, Calif. and New York City.
Boston Business Journal